Clindamycin HCl: Lincosamide Antibiotic
Clindamycin is a semisynthetic lincosamide antibiotic derived from lincomycin. It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit at the 23S rRNA, overlapping with the macrolide binding site. Clindamycin is particularly valued for its activity against anaerobic bacteria, staphylococci, and streptococci, and for its excellent penetration into bone tissue.
Product Profile
| CAS Number | 21462-39-5 |
|---|---|
| Molecular Formula | C18H33ClN2O5S·HCl |
| Appearance | White to off-white crystalline powder |
| Therapeutic Category | Lincosamide antibiotic |
| Storage | Room temperature |
Applications
Clindamycin HCl is used orally for serious infections caused by susceptible anaerobic bacteria, streptococci, and staphylococci, including bone and joint infections (osteomyelitis), intra-abdominal infections, and pelvic inflammatory disease. It is a preferred alternative in penicillin-allergic patients for dental and orthopedic prophylaxis. Topical clindamycin (1% gel, lotion, solution) is a standard treatment for acne vulgaris. Clindamycin phosphate is the salt used in parenteral and topical formulations. In veterinary medicine, clindamycin is used in dogs and cats for dental infections, osteomyelitis, and toxoplasmosis.
Why Source from TCS
TCS supplies clindamycin HCl to pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.
FAQ
What information should be included in an inquiry for Clindamycin HCl 21462-39-5?
A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.
How is Clindamycin HCl 21462-39-5 usually evaluated for sourcing?
This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.
What documentation and commercial points are commonly reviewed before buying Clindamycin HCl 21462-39-5?
For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.
Request a Quote
If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.